Noninvasive positive pressure ventilation in acute asthmatic attack
…, A Mizrachi, A Miller, TMB Yehuda… - European …, 2010 - Eur Respiratory Soc
Asthma is characterised by reversible airway obstruction. In most patients, control of disease
activity is easily achieved. However, in a small minority, asthma may be fatal. Between the …
activity is easily achieved. However, in a small minority, asthma may be fatal. Between the …
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a …
…, M Matsumura, MO Ozan, GS Mintz, O Ben-Yehuda… - The Lancet, 2016 - thelancet.com
Background Percutaneous coronary intervention (PCI) is most commonly guided by
angiography alone. Intravascular ultrasound (IVUS) guidance has been shown to reduce major …
angiography alone. Intravascular ultrasound (IVUS) guidance has been shown to reduce major …
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial
…, JM Paradis, AP Kappetein, O Ben-Yehuda… - American heart …, 2016 - Elsevier
… Nazif MD d e , Josep Rodés-Cabau MD c , Jean-Michel Paradis MD c , Arie-Pieter
Kappetein MD, PhD a , Ori Ben-Yehuda MD e , Gerrit-Anne van Es PhD f , Faouzi Kallel PhD g , …
Kappetein MD, PhD a , Ori Ben-Yehuda MD e , Gerrit-Anne van Es PhD f , Faouzi Kallel PhD g , …
[HTML][HTML] Intercellular nanotubes mediate bacterial communication
GP Dubey, S Ben-Yehuda - Cell, 2011 - cell.com
Bacteria are known to communicate primarily via secreted extracellular factors. Here we
identify a previously uncharacterized type of bacterial communication mediated by nanotubes …
identify a previously uncharacterized type of bacterial communication mediated by nanotubes …
[PDF][PDF] Utilizing IOMMUs for virtualization in Linux and Xen
IOMMUs are hardware devices that translate device DMA addresses to proper machine
physical addresses. IOMMUs have long been used for RAS (prohibiting devices from DMA’ing …
physical addresses. IOMMUs have long been used for RAS (prohibiting devices from DMA’ing …
[HTML][HTML] Meshed acellular dermal matrix in immediate prepectoral implant-based breast reconstruction
M Scheflan, TM Allweis, DB Yehuda… - … Surgery–Global Open, 2020 - journals.lww.com
Background: Prepectoral implant placement has many potential advantages in immediate
breast reconstruction. Acellular dermal matrices (ADMs) are commonly used in these surgeries…
breast reconstruction. Acellular dermal matrices (ADMs) are commonly used in these surgeries…
[PDF][PDF] Pathogenic E. coli extracts nutrients from infected host cells utilizing injectisome components
…, Y Socol, S Kobi, N Katsowich, S Ben-Yehuda… - Cell, 2019 - cell.com
Microbiota and intestinal epithelium restrict pathogen growth by rapid nutrient consumption.
We investigated how pathogens circumvent this obstacle to colonize the host. Utilizing …
We investigated how pathogens circumvent this obstacle to colonize the host. Utilizing …
Neurolymphomatosis: an international primary CNS lymphoma collaborative group report
…, A Nemets, E Shalom, D Ben-Yehuda… - Blood, The Journal …, 2010 - ashpublications.org
… Dina Ben-Yehuda, Dina Ben-Yehuda … Chamberlain, Patrick Roth, Anatoly Nemets, Edna
Shalom, Dina Ben-Yehuda, Tali Siegal; Neurolymphomatosis: an International Primary CNS …
Shalom, Dina Ben-Yehuda, Tali Siegal; Neurolymphomatosis: an International Primary CNS …
[HTML][HTML] Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
H Ben-Yehuda, M Arad, JM Peralta Ramos… - Molecular …, 2021 - Springer
Background For decades, dementia has been characterized by accumulation of waste in
the brain and low-grade inflammation. Over the years, emerging studies highlighted the …
the brain and low-grade inflammation. Over the years, emerging studies highlighted the …
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
…, L Arcaini, L Baldini, N Bellam, N Bartlett, DB Yehuda… - The Lancet, 2019 - thelancet.com
Background Based on the encouraging activity and manageable safety profile observed in
a phase 1 study, the ECHELON-2 trial was initiated to compare the efficacy and safety of …
a phase 1 study, the ECHELON-2 trial was initiated to compare the efficacy and safety of …